Boston Scientific Receives CE Mark Approval for REBELâ„¢ Platinum Chromium Coronary Stent System

[PR Newswire] – NATICK, Mass., March 12, 2014 /PRNewswire/ — Continuing to advance leading stent technology, Boston Scientific Corporation (BSX) has received CE Mark approval for the REBELâ„¢ Platinum Chromium Coronary Stent System, the company’s latest more

View todays social media effects on BSX

View the latest stocks trending across Twitter. Click to view dashboard

See who Boston is hiring next, click here to view